Bruker Co. (NASDAQ:BRKR) Stock Position Trimmed by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA decreased its position in Bruker Co. (NASDAQ:BRKR) by 21.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 6,361,538 shares of the medical research company’s stock after selling 1,727,330 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Bruker were worth $405,930,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in BRKR. TD Asset Management Inc increased its position in Bruker by 7.4% in the 1st quarter. TD Asset Management Inc now owns 1,788,763 shares of the medical research company’s stock valued at $168,036,000 after acquiring an additional 123,984 shares during the period. Congress Asset Management Co. MA raised its stake in shares of Bruker by 3.5% during the first quarter. Congress Asset Management Co. MA now owns 1,414,362 shares of the medical research company’s stock valued at $132,865,000 after purchasing an additional 47,301 shares in the last quarter. Norges Bank bought a new stake in shares of Bruker during the 4th quarter worth about $74,582,000. Bank of New York Mellon Corp lifted its stake in shares of Bruker by 3.0% in the 2nd quarter. Bank of New York Mellon Corp now owns 966,069 shares of the medical research company’s stock worth $61,645,000 after acquiring an additional 27,870 shares during the period. Finally, Janus Henderson Group PLC boosted its holdings in shares of Bruker by 3.5% in the first quarter. Janus Henderson Group PLC now owns 869,205 shares of the medical research company’s stock valued at $81,648,000 after acquiring an additional 29,566 shares in the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on BRKR. The Goldman Sachs Group dropped their target price on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a report on Tuesday, July 9th. Bank of America cut their price objective on Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a report on Monday, May 20th. Stifel Nicolaus decreased their target price on Bruker from $81.00 to $77.00 and set a “hold” rating for the company in a research note on Monday, May 20th. TD Cowen dropped their price target on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research report on Wednesday, August 7th. Finally, StockNews.com lowered shares of Bruker from a “buy” rating to a “hold” rating in a research report on Tuesday, May 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Bruker has an average rating of “Moderate Buy” and a consensus target price of $81.40.

Bruker Price Performance

NASDAQ BRKR opened at $65.28 on Tuesday. Bruker Co. has a 1 year low of $53.79 and a 1 year high of $94.86. The stock’s 50-day moving average price is $64.17 and its two-hundred day moving average price is $73.43. The company has a market cap of $9.49 billion, a PE ratio of 23.74, a PEG ratio of 2.31 and a beta of 1.18. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.52. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The business had revenue of $800.70 million for the quarter, compared to analyst estimates of $799.44 million. During the same quarter in the previous year, the business earned $0.50 earnings per share. The firm’s revenue was up 17.4% compared to the same quarter last year. On average, analysts predict that Bruker Co. will post 2.61 EPS for the current year.

Bruker Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Monday, September 2nd were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.31%. Bruker’s dividend payout ratio is 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.